Stay updated on Efficacy of EID Natalizumab in RRMS Clinical Trial
Sign up to get notified when there's something new on the Efficacy of EID Natalizumab in RRMS Clinical Trial page.

Latest updates to the Efficacy of EID Natalizumab in RRMS Clinical Trial page
- Check5 days agoChange DetectedThe website changelog now includes Revision: v3.3.4 and removes Revision: v3.3.3.SummaryDifference0.0%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedLocations section updated with numerous new site locations across the US, Canada, the UK, Spain, Australia, and other regions, and the previous location list was removed. The HHS Vulnerability Disclosure link was removed.SummaryDifference2%

- Check55 days agoChange DetectedThe page updates the note about publications to indicate they are automatically filled from PubMed and changes the revision to v3.3.2, replacing the previous wording that stated PubMed publications are automatically created and using revision v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check62 days agoChange DetectedA funding-status notice was removed from the page, while core study details remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check76 days agoChange DetectedThe changes appear to be minor page formatting updates and small text changes with no new core content or locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check105 days agoChange Detected- Added a government funding notice with operational details and links; - Updated version to v3.2.0; - Removed reference to v3.1.0.SummaryDifference2%

Stay in the know with updates to Efficacy of EID Natalizumab in RRMS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efficacy of EID Natalizumab in RRMS Clinical Trial page.